id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-264828-6w13xo2a	Albini, Adriana	The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies	2020-05-19		.txt	text/plain	3696	123	31	Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics HFSA/ACC/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19 Position Statement of the ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19 Renin-angiotensin-aldosterone system blockers and the risk of Cardiovascular disease, drug therapy, and mortality in Covid-19 Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19) Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19 Acknowledgements We thank Andrea Sonaglioni (Cardiology Unit, San Giuseppe Hospital-MultiMedica, Milan, Italy) and Mario Milco D'Elios (Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy) for helpful discussion and revision of the manuscript. Do ACE-Is and ARBs display similar or quantitatively divergent effects in COVID-19 patients? 2.	cache/cord-264828-6w13xo2a.txt	txt/cord-264828-6w13xo2a.txt
